Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
MarketGauge.com
TEVA: Teva Pharmaceutical Industries Ltd Stock Price Quote - Tel Aviv - Bloomberg
Teva Pharmaceutical $TEVA Investment Report
Teva (TEVA) Explores Sale of $2 Billion Active Ingredients Unit - Bloomberg
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva Cedes Spot as Israel's Biggest Firm in Blow to Prestige - Bloomberg
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva Earnings Miss by Record - Bloomberg
Teva Up on NYSE Following Morgan Stanley Stock Recommendation Upgrade | Ctech
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight
Teva Surges as Buffett's Investment Stokes Hopes of Recovery - Bloomberg
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Teva Says 2018 Profit Will Keep Falling as Generic Drug Slump Persists - Bloomberg
Teva considering potential sale of inflammatory bowel disease asset - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
